Dr Reddy launches 'Supanac' tablets

Hyderabad, Jan 16 (UNI) Dr Reddy's Laboratories has launched Supanac (Diclofenac Potassium 50 mg) tablets in India, increasing its offering in the Rs 2,700 crore Non-Steroidal Anti-Inflammatory Drug (NSAID) market.

The drug, with analgesic, anti-pyretic and anti-inflammatory properties licensed from Applied Pharma Research (APR) of Switzerland, is used for acute pain management, a release here said.

This patented product was developed by Dynamic Buffered Technology (DBT).

UNI VA DS GM 1806